$115.70
▲ +3.7% Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
Corcept Therapeutics Insider Sold Shares Worth $2,860,737, According to a Recent SEC Filing
Corcept Therapeutics Insider Sold Shares Worth $6,460,766, According to a Recent SEC Filing
Why Is Corcept (CORT) Down 1.2% Since Last Earnings Report?
Overview
52-week range
$29
$126
89% of range
Avg surprise (last 2)
+13.0%
Avg reaction (last 1)
+1.6%
100% positive
Latest IV / EM
39%
EM ±6.1% · $110 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.36 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.30 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.16 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $0.29 | $0.23 | +26.1% | — | — | earnings |
| Mon May 5, 2025 | Mar/2025 | $0.17 | $0.17 | 0.0% | — | +1.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.41 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.32 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.25 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.28 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.25 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $0.14 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $256M | $165M | — | $208M | $194M | $157M | — | $183M |
| Cost of revenue | $4M | $3M | — | $5M | $3M | $2M | — | $3M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $41M | $-50M | — | $10M | $27M | $3M | — | $47M |
| Net income | $43M | $-32M | — | $20M | $35M | $21M | — | $47M |
| EPS (diluted) | $0.36 | $-0.30 | — | $0.16 | $0.29 | $0.17 | — | $0.41 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $111M | $109M | $120M | $125M | $103M | $90M | $128M | $137M |
| Inventory | $13M | $13M | $13M | $12M | $12M | $14M | $12M | $8M |
| Total current assets | $440M | $426M | $485M | $541M | $443M | $439M | $472M | $467M |
| Total assets | $889M | $815M | $837M | $824M | $802M | $846M | $841M | $784M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $183M | $177M | $189M | $192M | $166M | $163M | $161M | $145M |
| Total equity | $706M | $638M | $648M | $632M | $636M | $683M | $680M | $639M |